Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 11,956 | 10,547 | 9,795 | 8,707 | 7,430 |
| Cost of Goods | 2,527 | 2,890 | 3,250 | 2,385 | 2,095 |
| Gross Profit | 9,428 | 7,656 | 6,545 | 6,323 | 5,336 |
| Operating Expenses | 12,590 | 10,506 | 10,093 | 9,186 | 10,862 |
| Operating Income | -2,634 | -1,960 | -3,298 | -2,479 | -5,431 |
| Other Income | 830 | 1,120 | 431 | -974 | 390 |
| Pre-tax Income | -1,805 | -840 | -2,867 | -3,453 | -5,042 |
| Net Income Continuous | -678 | -840 | -2,867 | -3,453 | -3,949 |
| Net Income | $-678 | $-840 | $-2,867 | $-3,453 | $-3,949 |
| EPS Basic Total Ops | 0.00 | -0.02 | -0.08 | -0.10 | -0.13 |
| EPS Basic Continuous Ops | 0.00 | -0.02 | -0.08 | -0.10 | -0.12 |
| EPS Diluted Total Ops | 0.00 | -0.02 | -0.08 | -0.10 | -0.13 |
| EPS Diluted Continuous Ops | 0.00 | -0.02 | -0.08 | -0.10 | -0.12 |
| EBITDA(a) | $-2,253 | $-1,769 | $-3,103 | $-2,262 | $-5,228 |